MedPath

Influence of different products on the effectiveness and duration of treatment of sensitive teeth and patients' well-being

Not Applicable
Recruiting
Conditions
Dentin sensitivity
C07.465
Registration Number
RBR-109h3wcv
Lead Sponsor
niversidade Federal de Uberlândia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Patients with dentin hypersensitivity in at least 3 teeth with loss of tooth structure of less than 1mm; moderate to severe dentin hypersensitivity (pain greater than 3); Individuals who are interested in the treatment of dentin hypersensitivity; agree to participate and sign the free and informed consent form; participants aged between 18 and 60

Exclusion Criteria

Presence of dentin sensitivity caused by the presence of caries or unsatisfactory restorations; patient undergoing orthodontic or periodontal treatment; patients undergoing teeth whitening; presence of spontaneous pain in the tooth with dentin hypersensitivity, characterizing pulpitis; presence of periodontal disease; poor and unsatisfactory oral hygiene; use of extensive prostheses; patients with severe bruxism and changes in vertical dimension; patients with uncontrolled gastroesophageal reflux disease; patients with uncontrolled systemic or psychological illnesses; patients who use controlled medications that interfere with salivary flow; pregnant and lactating women; smokers

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
It is expected that the universal adhesive system and flow resin as obliterating agents improve the effectiveness and durability of the treatment of dentin hypersensitivity when compared to the use of potassium nitrate associated with glutaraldehyde, control group
Secondary Outcome Measures
NameTimeMethod
Evaluate the periodontal condition of patients, determined through clinical assessment before the intervention and within 7, 30, 90 and 180 days for follow-up;Evaluate patients' quality of life, determined through the quality of life questionnaire, before the intervention and within 90 and 180 days for follow-up
© Copyright 2025. All Rights Reserved by MedPath